These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38801782)
1. Localized anaplastic lymphoma kinase-positive histiocytosis in a cerebellar hemisphere with long-term treatment: illustrative case. Kumagai E; Tanaka M; Iwasaki F; Yanagimachi M; Hirokawa D; Goto H; Tanaka Y J Neurosurg Case Lessons; 2024 May; 7(22):. PubMed ID: 38801782 [TBL] [Abstract][Full Text] [Related]
2. Multisystem ALK-positive histiocytosis: a multi-case study and literature review. Liu W; Liu HJ; Wang WY; Tang Y; Zhao S; Zhang WY; Yan JQ; Liu WP Orphanet J Rare Dis; 2023 Mar; 18(1):53. PubMed ID: 36915094 [TBL] [Abstract][Full Text] [Related]
3. ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology. Kashima J; Yoshida M; Jimbo K; Izutsu K; Ushiku T; Yonemori K; Yoshida A Am J Surg Pathol; 2021 Mar; 45(3):347-355. PubMed ID: 32826530 [TBL] [Abstract][Full Text] [Related]
4. ALK-positive histiocytosis with disseminated disease responded to alectinib: a case report. Tian Y; Li J; Liu B; Xie H; Zheng M; Yao W Ann Palliat Med; 2021 Sep; 10(9):10095-10101. PubMed ID: 34628929 [TBL] [Abstract][Full Text] [Related]
5. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Kemps PG; Picarsic J; Durham BH; Hélias-Rodzewicz Z; Hiemcke-Jiwa L; van den Bos C; van de Wetering MD; van Noesel CJM; van Laar JAM; Verdijk RM; Flucke UE; Hogendoorn PCW; Woei-A-Jin FJSH; Sciot R; Beilken A; Feuerhake F; Ebinger M; Möhle R; Fend F; Bornemann A; Wiegering V; Ernestus K; Méry T; Gryniewicz-Kwiatkowska O; Dembowska-Baginska B; Evseev DA; Potapenko V; Baykov VV; Gaspari S; Rossi S; Gessi M; Tamburrini G; Héritier S; Donadieu J; Bonneau-Lagacherie J; Lamaison C; Farnault L; Fraitag S; Jullié ML; Haroche J; Collin M; Allotey J; Madni M; Turner K; Picton S; Barbaro PM; Poulin A; Tam IS; El Demellawy D; Empringham B; Whitlock JA; Raghunathan A; Swanson AA; Suchi M; Brandt JM; Yaseen NR; Weinstein JL; Eldem I; Sisk BA; Sridhar V; Atkinson M; Massoth LR; Hornick JL; Alexandrescu S; Yeo KK; Petrova-Drus K; Peeke SZ; Muñoz-Arcos LS; Leino DG; Grier DD; Lorsbach R; Roy S; Kumar AR; Garg S; Tiwari N; Schafernak KT; Henry MM; van Halteren AGS; Abla O; Diamond EL; Emile JF Blood; 2022 Jan; 139(2):256-280. PubMed ID: 34727172 [TBL] [Abstract][Full Text] [Related]
6. Failure of crizotinib based systemic treatment in ALK positive histiocytosis involving the central nervous system: a case report and literature review. He Q; Zhang W; Li Q BMC Pediatr; 2022 May; 22(1):308. PubMed ID: 35614430 [TBL] [Abstract][Full Text] [Related]
7. Case report: ALK-positive histiocytosis presented as bilateral synchronous breast masses with long-term remission on crizotinib. Zhou Y; Hurtado-Castillo M; Pandey O Front Med (Lausanne); 2023; 10():1288849. PubMed ID: 38093982 [TBL] [Abstract][Full Text] [Related]
8. Distinct Clinicopathologic Features and Possible Pathogenesis of Localized ALK-positive Histiocytosis of the Breast. Osako T; Kurisaki-Arakawa A; Dobashi A; Togashi Y; Baba S; Shiozawa S; Ishigame H; Ishige H; Ohno S; Ishikawa Y; Takeuchi K Am J Surg Pathol; 2022 Mar; 46(3):344-352. PubMed ID: 34482333 [TBL] [Abstract][Full Text] [Related]
9. ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion. Chang KTE; Tay AZE; Kuick CH; Chen H; Algar E; Taubenheim N; Campbell J; Mechinaud F; Campbell M; Super L; Chantranuwat C; Yuen ST; Chan JKC; Chow CW Mod Pathol; 2019 May; 32(5):598-608. PubMed ID: 30573850 [TBL] [Abstract][Full Text] [Related]
10. ALK-positive histiocytosis in 12 Asian children. Feng X; Tao J; He N; Wang J; He L; Zhang N Hum Pathol; 2024 Oct; 152():105637. PubMed ID: 39117024 [TBL] [Abstract][Full Text] [Related]
11. ALK-rearranged histiocytosis: Report of two cases with involvement of the central nervous system. Rossi S; Gessi M; Barresi S; Tamburrini G; Giovannoni I; Ruggiero A; Colafati GS; Frassanito P; Carboni A; Alexandre A; Cacchione A; Trombatore P; Diomedi-Camassei F; Gaspari S; Gianno F; Marras CE; Cecinati V; Carai A; Mastronuzzi A; Alaggio R Neuropathol Appl Neurobiol; 2021 Oct; 47(6):878-881. PubMed ID: 34048085 [TBL] [Abstract][Full Text] [Related]
13. Expanding the Phenotype of ALK-positive Histiocytosis: A Report of 2 Cases. Huang H; Gheorghe G; North PE; Suchi M Pediatr Dev Pathol; 2018; 21(5):449-455. PubMed ID: 29224419 [TBL] [Abstract][Full Text] [Related]
15. Case Report: ALK-Positive Histiocytosis With Guo Y; Qu HB; Ning G; Jia FL; Liu H; Ma XM; Liao Y Front Oncol; 2022; 12():858939. PubMed ID: 35359354 [TBL] [Abstract][Full Text] [Related]
16. Strategy for Pediatric Patients with Relapsed or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: A Review. Noguchi K; Ikawa Y Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136278 [TBL] [Abstract][Full Text] [Related]
17. Local ALK-Positive Histiocytosis With Unusual Morphology and Novel Tran TAN; Chang KTE; Kuick CH; Goh JY; Chang CC Int J Surg Pathol; 2021 Aug; 29(5):543-549. PubMed ID: 33243034 [TBL] [Abstract][Full Text] [Related]
18. Localized ALK-positive histiocytosis in a Chinese woman: report of a case in the lung with a novel EML4-ALK rearrangement. Bai Y; Sun W; Niu D; Yang X; Diao X; Yu Y; Lin D Virchows Arch; 2021 Dec; 479(6):1079-1083. PubMed ID: 33825946 [TBL] [Abstract][Full Text] [Related]
19. Anaplastic lymphoma kinase inhibitor therapy in the treatment of inflammatory myofibroblastic tumors in pediatric patients: Case reports and literature review. Craig E; Wiltsie LM; Beaupin LK; Baig A; Kozielski R; Rothstein DH; Li V; Twist CJ; Barth M J Pediatr Surg; 2021 Dec; 56(12):2364-2371. PubMed ID: 33676744 [TBL] [Abstract][Full Text] [Related]